Geoffrey Falkson
Impact in
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies
- Oncology top 0.5%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
Papers in
- Oncology 126
- Cancer Treatment and Pharmacology 78
- Colorectal Cancer Treatments and Studies 16
-
- Lung Cancer Treatments and Mutations 20
- Co-authors
- H. C. Falkson (29 shared papers)Douglass C. Tormey (19 shared papers)Carla I. Falkson (26 shared papers)W. R. Bezwoda (5 shared papers)L. Goedhals (4 shared papers)D C Tormey (16 shared papers)Charles G. Moertel (3 shared papers)Rebecca Gelman (15 shared papers)
- Journals
- Cancer (36 papers)Journal of Clinical Oncology (27 papers)Investigational New Drugs (13 papers)Oncology (11 papers)Cancer Chemotherapy and Pharmacology (9 papers)
- Partner nations
- South AfricaUnited StatesSwitzerland
In The Last Decade
Geoffrey Falkson
252 papers receiving 6.2k citations
Peers
Comparison fields: 5 of 128
- Cancer Research 1.7k
- Oncology 2.7k
- Hepatology 400
- Pulmonary and Respiratory Medicine 1.6k
- Pathology and Forensic Medicine 759
Countries citing papers authored by Geoffrey Falkson
This map shows the geographic impact of Geoffrey Falkson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoffrey Falkson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoffrey Falkson more than expected).
Fields of papers citing papers by Geoffrey Falkson
This network shows the impact of papers produced by Geoffrey Falkson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoffrey Falkson. The network helps show where Geoffrey Falkson may publish in the future.
Co-authors
The 25 scholars most cited alongside Geoffrey Falkson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 264 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 474 | |
| 2 | 1999 | 341 | |
| 3 | 1994 | 312 | |
| 4 | 1989 | 275 | |
| 5 | 1988 | 185 | |
| 6 | 1978 | 182 | |
| 7 | 1984 | 171 | |
| 8 | 1962 | 133 | |
| 9 | 1991 | 131 | |
| 10 | 1982 | 127 | |
| 11 | 1997 | 112 | |
| 12 | 1983 | 102 | |
| 13 | 1992 | 98 | |
| 14 | 1993 | 93 | |
| 15 | 1987 | 91 | |
| 16 | 1984 | 90 | |
| 17 | 2001 | 87 | |
| 18 | Prognostic factors for survival in hepatocellular carcinoma. | 1988 | 84 |
| 19 | Unexpected toxicity in patients treated with iphosphamide. | 1972 | 80 |
| 20 | 1975 | 79 |
About Geoffrey Falkson
Geoffrey Falkson is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Pathology and Forensic Medicine, having authored 264 papers that have together received 6.7k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (78 papers), Breast Cancer Treatment Studies (41 papers), Lung Cancer Treatments and Mutations (20 papers), Lymphoma Diagnosis and Treatment (20 papers), Hepatocellular Carcinoma Treatment and Prognosis (17 papers), Colorectal Cancer Treatments and Studies (16 papers), Estrogen and related hormone effects (16 papers) and Cancer therapeutics and mechanisms (16 papers). The work is most often cited by research in Cancer Research (1.7k citations), Oncology (2.7k citations), Hepatology (400 citations), Pulmonary and Respiratory Medicine (1.6k citations) and Pathology and Forensic Medicine (759 citations). Geoffrey Falkson has collaborated with scholars based in South Africa, United States and Switzerland. Frequent co-authors include H. C. Falkson, Douglass C. Tormey, Carla I. Falkson, W. R. Bezwoda, L. Goedhals, D C Tormey, Charles G. Moertel, Rebecca Gelman, John Macintyre and E. Schulz. Their work appears in journals such as Cancer, Journal of Clinical Oncology, Investigational New Drugs, Oncology and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.